Shone's syndrome is a rare, complex congenital heart disease characterized by the combination of multiple obstructions within the left heart, which interfere with normal blood flow from the pulmonary circulation to the systemic circulation. In its classic form, first described in 1963 by Shone et al., the syndrome includes four lesions: supravalvular mitral ring, parachute mitral valve, subaortic stenosis, and coarctation of the aorta. However, incomplete forms (so-called "partial Shone’s syndrome") exist, in which only two or three of the characteristic anomalies are present. The overall hemodynamic effect is a progressive obstruction of the left ventricular outflow tract, resulting in upstream pressure overload, impaired cardiac growth, and compromised left ventricular function.
The etiology of Shone's syndrome lies in an early developmental anomaly of the valvular and vascular structures of the left heart, typically occurring between the fourth and seventh week of gestation. A disruption in the formation of the endocardial cushion and mesenchymal tissues involved in the development of the atrioventricular septum, mitral apparatus, and proximal aorta leads to a series of interrelated morphological defects.
Specifically, the following abnormalities are observed:
Risk factors are not always identifiable, but associations have been reported with genetic mutations involved in cardiac morphogenesis, particularly alterations in genes such as NOTCH1, GATA4, or SMAD6. An increased incidence has also been reported in patients with complex genetic syndromes, including Turner syndrome. Familial clustering of congenital left ventricular outflow tract obstruction has also been documented. Nevertheless, the origin remains sporadic in most cases.
The pathogenetic mechanism is based on the combined effect of the various obstructions, leading to increased upstream pressure and reduced downstream flow. The supravalvular mitral ring causes impaired filling of the left ventricle, which results in left atrial hypertrophy and elevated pulmonary venous pressure. The parachute mitral valve, with its rigid and asymmetric motion, further worsens diastolic filling, increasing the risk of functional mitral stenosis. Subaortic stenosis reduces systolic outflow and imposes a pressure overload on the left ventricle, which may undergo concentric hypertrophy and progressive dysfunction. Finally, aortic coarctation causes an additional impediment to systemic flow, contributing to a vicious cycle of distal hypoperfusion and proximal hypertension.
From a pathophysiological standpoint, Shone’s syndrome presents as a progressive obstructive cardiopathy of the left heart, impairing both diastolic and systolic function. The simultaneous presence of multiple obstructions results in a precarious hemodynamic balance: the left atrium and pulmonary circulation are exposed to high pressures, with a risk of congestion and pulmonary hypertension. The left ventricle is forced to work against increased resistance, leading to hypertrophy and, over time, decreased compliance and contractile function. The final effect is a combination of left ventricular failure, impaired systemic perfusion, and, in severe cases, early heart failure.
The anatomical variability and the sequence in which the individual components develop result in a broad clinical and prognostic spectrum, ranging from subclinical forms with incidental findings to critical neonatal presentations with severe symptoms at birth.
The clinical picture of Shone’s syndrome depends on the combination and severity of the obstructions present along the left ventricular outflow tract. In complete forms, which include hypoplasia of the mitral annulus, supramitral membrane, stenotic aortic valve, and aortic coarctation, symptoms develop early, sometimes within the first hours of life. Incomplete or less severe forms may remain clinically silent until childhood or later, with a subtle and progressive onset.
In neonates, the onset is generally acute, linked to the deterioration of systemic circulation following the physiological closure of the ductus arteriosus. Initial symptoms include poor sucking, failure to thrive, fatigue, and excessive sleepiness.
As systemic flow obstruction worsens, tachypnea, progressive dyspnea, and irritability appear, indirect signs of pulmonary venous congestion and elevated left atrial pressure.
In this context, central cyanosis is a frequent but not constant clinical finding. It typically occurs in cases with marked pulmonary venous hypertension, reduced systemic venous return, or right-to-left atrial shunting. It may be absent in milder forms where signs of systemic failure or subacute hemodynamic congestion predominate.
Physical examination reveals tachycardia, weak pulses, and, in the presence of significant coarctation, brachial-femoral pulse delay or asymmetry. Breathing is shallow, with intercostal retractions and nasal flaring. Heart sounds are loud, and systolic murmurs are often auscultated at the apex or left parasternal region, related to turbulent flow through stenotic mitral and aortic valves. Hepatomegaly and oliguria are common signs indicating evolving heart failure.
In older children or adolescents, the presentation may be more subtle but progressive. The most common symptoms include:
The clinical course, if untreated, is progressive and relentless. The simultaneous presence of multiple obstructions along the left ventricular outflow tract results in chronic pressure overload, inducing left ventricular remodeling, diastolic dysfunction, and decreased contractile reserve.
The left heart, subjected to high pressure gradients, develops structural and functional changes culminating in worsening congestive heart failure. In untreated cases, the natural history leads to early cardiac death or the need for heart transplantation during childhood.
The diagnosis of Shone’s syndrome requires an integrated approach starting from clinical evaluation and supported by advanced instrumental investigations. Suspicion arises in the presence of signs of left ventricular outflow tract obstruction, especially if multiple, and symptoms of left heart failure or systemic hypoperfusion in the neonatal or infant period. In some cases, diagnosis can be made prenatally by fetal echocardiography, revealing mitral valve anomalies, aortic narrowing, or coarctation.
Transthoracic echocardiography (TTE) is the first-choice diagnostic tool, allowing direct identification of the four characteristic lesions of the syndrome. It enables morphological and functional assessment of the mitral valve, detection of a supravalvular ring, presence of a single papillary muscle insertion in the parachute mitral valve, features of subaortic stenosis (fibrous membrane, muscular ridge), and extent of aortic coarctation. Color Doppler echocardiography is essential for analyzing pressure gradients and transvalvular flows, as well as for studying the overall hemodynamic pattern.
In cases of suboptimal images, complex anatomy, or need for preoperative planning, advanced imaging techniques such as cardiac magnetic resonance (CMR) or cardiac computed tomography (CT) are indicated. These provide accurate three-dimensional visualization of anatomy and associated vascular structures, useful for comprehensive definition of coarctation and complex mitral anomalies.
Cardiac catheterization is reserved for selected cases, especially when diagnostic discrepancies occur, to measure pressure gradients directly, pulmonary vascular resistance, and to perform interventional procedures if indicated (e.g., balloon dilation of stenoses or ventricular compliance assessment). In critical neonates, it may be necessary to confirm ductal patency or to perform an atrial septostomy.
The differential diagnosis includes numerous congenital left heart obstructive lesions, particularly isolated coarctation, congenital mitral stenosis, bicuspid aortic valve with critical stenosis, and hypoplastic left heart syndromes. Precise distinction is essential for planning appropriate treatment and defining long-term risk.
Treatment of Shone’s syndrome is complex and requires a multidisciplinary approach, personalized according to the morphology and severity of individual lesions. The goal is to progressively relieve left ventricular outflow tract obstructions, improve ventricular function, and prevent progression of heart failure. Management occurs in specialized pediatric cardiac surgery centers and often involves a combination of medical, percutaneous, and surgical interventions staged over time.
In the neonatal phase, treatment aims to stabilize the infant by maintaining ductal patency with prostaglandin E1, respiratory support, and correction of metabolic disturbances. In the presence of severe and early obstructions, urgent surgical intervention may be required to correct coarctation or to enlarge mitral inflow in case of critical supravalvular ring or parachute mitral valve.
Surgical treatment includes resection of the supravalvular mitral ring, commissurotomy or remodeling of the parachute mitral valve, resection of the subaortic membrane, valve replacement in severe cases, and correction of aortic coarctation by resection with end-to-end anastomosis or prosthetic graft implantation. In selected cases, hybrid strategies or palliative percutaneous procedures such as balloon dilation or stenting of stenotic segments may be employed.
Long-term follow-up is essential, as Shone’s syndrome is a dynamic condition prone to progression. Even after initial correction, new stenoses or valvular regurgitations, ventricular compliance alterations, diastolic dysfunction, or persistent systemic hypertension may develop. Monitoring should include serial echocardiographic evaluations, periodic clinical assessments, and, in complex cases, advanced imaging and stress testing.
Prognosis varies widely depending on syndrome completeness, timing of diagnosis, and success of interventions. Isolated partial forms involving a single component generally have a more favorable course. In complete cases, long-term survival has improved with technical and surgical advances but remains conditioned by residual ventricular function and risk of late complications.
Complications of Shone’s syndrome can occur throughout the clinical course, both in untreated natural history and post-surgical follow-up.
Progressive obstruction of left heart structures, if uncorrected, leads to congestive heart failure, pulmonary hypertension, and chronic systemic hypoperfusion.
The main complications observed after treatment include:
In patients with more complex forms or significant hemodynamic residues, the risk of ventricular failure, reduced exercise tolerance, and deterioration in quality of life increases over time. In rare refractory cases, heart transplantation may become necessary.
Optimal management requires multidisciplinary surveillance, with timely interventions on recurrent stenoses, organ dysfunction, or blood pressure abnormalities to improve event-free survival and long-term quality of life.